Clinical and genetic profile of lower limb dystonia: a dual-center retrospective study in China
4 affiliations
- 1Department of Geriatric Medicine and Laboratory of Gerontology and Anti-Aging Research, Qilu Hospital of Shandong University
- 2Department of Neurology, The First Hospital of Tsinghua University
- 3Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
- 4Department of Neurology, Qilu Hospital of Shandong University
Abstract
Background: Lower limb dystonia (LLD) is a clinically significant form of dystonia that can substantially impair gait and quality of life. Its clinical presentation is highly heterogeneous, and investigations into underlying genetic causes remain limited. This study aimed to characterize the clinical and genetic profile of LLD in a Chinese cohort and to explore potential genotype–phenotype correlations.
Methods: Patients diagnosed with LLD without an acquired cause were retrospectively enrolled at two movement disorder centers in China between January 2016 and December 2024. Clinical characteristics were collected, and genetic testing results were comprehensively analyzed.
Results: A total of 68 patients with LLD without an acquired cause were included. The median age at dystonia onset was 14.0 years (IQR, 6.3–23.0 years), with 46 patients (67.6%) developing symptoms before the age of 20 years. Foot dystonia was the most common initial manifestation, presenting as foot inversion (25.0%) and foot plantarflexion (20.6%). At the last follow-up, 35 patients (51.5%) remained restricted to lower limbs involvement (LLD group), whereas the remaining 33 patients (48.5%) developed dystonia spreading to other anatomical regions (LLD-plus group). Pathogenic or likely pathogenic variants were identified in 29 patients (42.6%), involving TOR1A ( n = 8), GCH1 ( n = 6), KMT2B ( n = 5), PRKN ( n = 5), TH ( n = 2), SGCE ( n = 1), PINK1 ( n = 1), and PANK2 ( n = 1). The distribution of causative genes differed between the two groups. GCH1 and PRKN were the most frequently implicated genes in the LLD group, whereas TOR1A and KMT2B were the predominant causative genes in the LLD-plus group.
Conclusion: LLD in the Chinese cohort is a clinically and genetically heterogeneous disorder, with a substantial proportion of patients harboring identifiable monogenic causes.
Related
- Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study
- Clinicopathological Profile, Treatment Patterns and Documented Clinical Outcomes of Women with Breast Cancer at Shendi Hospital, Sudan: A Retrospective, Single-Center, Hospital-Based Cross-Sectional Study.
- Clinical and genetic characteristics of patients with early-onset or familial parkinsonism: A retrospective single-center cohort
- Clinical, Functional, and Radiological Profile of Patients With Spondyloarthritis: A Cross-Sectional Study From a Tertiary Care Center in Central India
- Epidemiological, Clinical, and Etiological Profile of Iron Deficiency Anemia in Adults in Southern Morocco: A Five-Year Retrospective Study
BibTeX
@article{ma2026clinical,
title = {{Clinical and genetic profile of lower limb dystonia: a dual-center retrospective study in China}},
author = {Jun Ma and Shanglin Li and Lin Wang and Yingmai Yang and Wenjing Jiang and Xinhua Wan and Yiming Liu},
journal = {Frontiers in Neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1957431},
url = {https://www.frontiersin.org/articles/10.3389/fneur.2026.1957431/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Clinical and genetic profile of lower limb dystonia: a dual-center retrospective study in China
AU - Jun Ma
AU - Shanglin Li
AU - Lin Wang
AU - Yingmai Yang
AU - Wenjing Jiang
AU - Xinhua Wan
AU - Yiming Liu
PY - 2026
DA - 2026/10/30
JO - Frontiers in Neurology
DO - 10.3389/fneur.2026.1957431
UR - https://www.frontiersin.org/articles/10.3389/fneur.2026.1957431/full
AB - Background: Lower limb dystonia (LLD) is a clinically significant form of dystonia that can substantially impair gait and quality of life. Its clinical presentation is highly heterogeneous, and investigations into underlying genetic causes remain limited. This study aimed to characterize the clinical and genetic profile of LLD in a Chinese cohort and to explore potential genotype–phenotype correlations. Methods: Patients diagnosed with LLD without an acquired cause were retrospectively enrolled at two movement disorder centers in China between January 2016 and December 2024. Clinical characteristics were collected, and genetic testing results were comprehensively analyzed. Results: A total of 68 patients with LLD without an acquired cause were included. The median age at dystonia onset was 14.0 years (IQR, 6.3–23.0 years), with 46 patients (67.6%) developing symptoms before the age of 20 years. Foot dystonia was the most common initial manifestation, presenting as foot inversion (25.0%) and foot plantarflexion (20.6%). At the last follow-up, 35 patients (51.5%) remained restricted to lower limbs involvement (LLD group), whereas the remaining 33 patients (48.5%) developed dystonia spreading to other anatomical regions (LLD-plus group). Pathogenic or likely pathogenic variants were identified in 29 patients (42.6%), involving TOR1A ( n = 8), GCH1 ( n = 6), KMT2B ( n = 5), PRKN ( n = 5), TH ( n = 2), SGCE ( n = 1), PINK1 ( n = 1), and PANK2 ( n = 1). The distribution of causative genes differed between the two groups. GCH1 and PRKN were the most frequently implicated genes in the LLD group, whereas TOR1A and KMT2B were the predominant causative genes in the LLD-plus group. Conclusion: LLD in the Chinese cohort is a clinically and genetically heterogeneous disorder, with a substantial proportion of patients harboring identifiable monogenic causes.
SN - 1664-2295
ER -